Author

Johanna ter Burg

Observed names: J ter Burg, Johanna Ter Burg

Institution: Amsterdam University Medical Centers

Observed institutions: Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, University of Amsterdam

OpenAlex ID: A5041137116

Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL

2020 · Marco V. Haselager, Karoline Kielbassa, et al. · Blood · 118

Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia

2016 · Rachel Thijssen, Johanna ter Burg, et al. · Blood · 71

Functional disparities among BCL-2 members in tonsillar and leukemic B-cell subsets assessed by BH3-mimetic profiling

2016 · Victor Peperzak, Erik Slinger, et al. · Cell Death and Differentiation · 28

The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

2015 · R Thijssen, J ter Burg, et al. · Leukemia · 22

Dissection of the Effects of JAK and BTK Inhibitors on the Functionality of Healthy and Malignant Lymphocytes

2019 · Tom Hofland, Iris de Weerdt, et al. · The Journal of Immunology · 21

Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia

2021 · Raquel Delgado, Karoline Kielbassa, et al. · Cancers · 10

Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival

2019 · Simar Pal Singh, Marjolein J. W. de Bruijn, et al. · The Journal of Immunology · 6

Dissecting the Role of Individual Bcl-2 Members in Response and Resistance to Ibrutinib or Venetoclax in CLL

2017 · Fabio Brocco, Hanneke ter Burg, et al. · Blood · 5

Bcl-2 Members As Drug Target and Biomarkers for Response to Ibrutinib and Venetoclax in CLL

2016 · Eric Eldering, Victor Peperzak, et al. · Blood · 3

Erratum: The pan phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor SAR245409 (voxtalisib/XL765) blocks survival, adhesion and proliferation of primary chronic lymphocytic leukemia cells

2016 · R Thijssen, J ter Burg, et al. · Leukemia · 3

Combined Inhibition of mTOR and DNA-PK Blocks Survival, Adhesion, Proliferation and Chemoresistance in Primary Chronic Lymphocytic Leukemia (CLL) Cells

2014 · Rachel Thijssen, Gregor van Bochove, et al. · Blood · 3

Linking Microenvironmental Signals to Metabolic Switches and Drug Responses in Chronic Lymphocytic Leukemia

2019 · Zhenghao Chen, Gaspard Cretenet, et al. · Blood · 1

Combined Inhibition of Phosphatidylinositol 3-Kinase (PI3K) Isoform α and δ By the Pan-Class I PI3K Inhibitor SAR245409 (XL765) in Primary Chronic Lymphocytic Leukemia Cells Blocks Survival, Adhesion and Proliferation

2014 · Rachel Thijssen, Gregor van Bochove, et al. · Blood · 1

Abstract 3554: Functional disparity among BCL-2 members in tonsillar and leukemic B cell subsets probed by next generation BH3 mimetic profiling

2016 · Victor Peperzak, Rachel Thijssen, et al. · Cancer Research

Works count: 9

Citation count: 262

H-index: 6

I10-index: 5